Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phospholipase A2 in schizophrenia]

D Rípová1, I Farská, V Nĕmcová

  • 1Psychiatrické centrum Praha.

Ceska a Slovenska Psychiatrie
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D in anxiety and affective disorders.

Physiological research·2015
Same author

The steroid metabolome in men with mood and anxiety disorders.

Physiological research·2015
Same author

A genome-wide association study of anorexia nervosa.

Molecular psychiatry·2014
Same author

Stress perception and (GT)n repeat polymorphism in haem oxygenase 1 promoter are both risk factors in development of eating disorders.

Folia biologica·2014
Same author

The interaction of standard oxime reactivators with hemicholinium-3 sensitive choline carriers.

Toxicology letters·2012
Same author

Preadipocyte factor-1 concentrations in patients with anorexia nervosa: the influence of partial realimentation.

Physiological research·2012

Phospholipase A2 (PLA2) is not a specific marker for schizophrenia. Current evidence does not support PLA2

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Schizophrenia is a complex psychiatric disorder with multifactorial etiology.
  • Phospholipase A2 (PLA2) enzymes are involved in various cellular processes, including inflammation and lipid metabolism.
  • Previous research has explored the potential involvement of PLA2 in the neurobiological underpinnings of schizophrenia.

Purpose of the Study:

  • To critically evaluate the role of phospholipase A2 (PLA2) in the pathogenesis of schizophrenia.
  • To synthesize existing literature data and original experimental findings concerning PLA2 and schizophrenia.

Main Methods:

  • Comprehensive review of relevant scientific literature.
  • Analysis of the authors' own experimental data on PLA2 in schizophrenia.

Related Experiment Videos

Main Results:

  • The available data, including the authors' findings, do not establish phospholipase A2 as a specific biomarker for schizophrenia.
  • The evidence does not conclusively link PLA2 activity or levels to the specific pathogenesis of schizophrenia.

Conclusions:

  • Phospholipase A2 (PLA2) is not currently considered a specific diagnostic marker for schizophrenia.
  • Further research is needed to fully elucidate the potential, non-specific role of PLA2 in schizophrenia.